![](/img/cover-not-exists.png)
The impact of BRAF mutation status on clinical outcomes with antiâPDâ1 monotherapy versus combination ipilimumab/nivolumab in treatmentânaïve advanced stage melanoma
Ma, Vincent T., DaignaultâNewton, Stephanie, Waninger, Jessica J., Journey, Sara, Chopra, Zoey, Tezel, Alangoya, Redman, Bruce G., Fecher, Leslie A., Green, Michael D., Alva, Ajjai S., Lao, ChristopJournal:
Pigment Cell & Melanoma Research
DOI:
10.1111/pcmr.12944
Date:
October, 2020
File:
PDF, 12.79 MB
2020